Risk of Venous Thromboembolism in Patients With Acne Receiving Spironolactone vs Tetracycline-Class Antibiotics
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Spironolactone use for acne is not associated with an increased risk of venous thromboembolism: A matched, retrospective cohort study
J Am Acad Dermatol 2023 Feb 25;[EPub Ahead of Print], A Shields, K Flood, JS BarbieriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.